Dyne Therapeutics, Inc. (DYN): Price and Financial Metrics
GET POWR RATINGS... FREE!
DYN Stock Price Chart Interactive Chart >
DYN Price/Volume Stats
| Current price | $13.74 | 52-week high | $15.63 |
| Prev. close | $14.05 | 52-week low | $4.30 |
| Day low | $13.70 | Volume | 114,812 |
| Day high | $14.07 | Avg. volume | 283,642 |
| 50-day MA | $12.68 | Dividend yield | N/A |
| 200-day MA | $10.45 | Market Cap | 716.22M |
Dyne Therapeutics, Inc. (DYN) Company Bio
Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States.
Latest DYN News From Around the Web
Below are the latest news stories about DYNE THERAPEUTICS INC that investors may wish to consider to help them evaluate DYN as an investment opportunity.
TipRanks ‘Perfect 10’ List: Strong Catalysts Confirm the Bull Thesis on These 2 StocksAll investors are after gains, but in trying to find the right stocks to increase a portfolio’s value, are constantly inundated with massive amounts of data. Thus, separating the wheat from the chaff is an arduous process but there are tools to help make sense of it all. TipRanks’ Smart Score is one. The tool collects all the info needed on any given stock and sorts it out into 8 different categories, all known to impact future performance. Combining those factors, they are then distilled into a |
Diving Into Dyne Therapeutics (NASDAQ:DYN)Dyne Therapeutics, Inc. has enjoyed a recent bounce from good news from a rival, more than tripling in price. Click here to see our take on DYN stock. |
Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer TherapeuticsDyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics are part of the Zacks Industry Outlook article. |
5 Stocks to Buy as the Drug Industry Bets Big on InnovationInnovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions to one's portfolio. |
Dyne Therapeutics Inc. (NASDAQ:DYN) Up 66.82% Since 52-Week Low; YTD Rose 11.82% – Here’s What You Need To DoDyne Therapeutics Inc. (NASDAQ:DYN)’s traded shares stood at 0.44 million during the last session. At the close of trading, the stock’s price was $12.96, to imply an increase of 8.82% or $1.05 in intraday trading. The DYN share’s 52-week high remains $15.63, putting it -20.6% down since that peak but still an impressive 66.82% since … Dyne Therapeutics Inc. (NASDAQ:DYN) Up 66.82% Since 52-Week Low; YTD Rose 11.82% – Here’s What You Need To Do Read More » |
DYN Price Returns
| 1-mo | 20.00% |
| 3-mo | 30.98% |
| 6-mo | 14.02% |
| 1-year | 99.13% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 18.55% |
| 2022 | -2.52% |
| 2021 | -43.38% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...